Collectively, these data suggest that ITGB1 on tumor cells might likely expedite chordoma progression by inducing an inhibitory immune microenvironment through recruiting SPP1+ TAMs, although the precise molecular mechanisms deserve further exploration. This evidence concerns the gene ITGB1 and neoplasm.